Death and survival of cardiomyocytes in acute ischemia

Korean Circulation Journal

Volumn 36, Issue 3, 2006, Pages 165-177

  Lee, Soo Hoon ^a   Kim, Young Dae ^b,c  

^a Ulsan General Hospital   (South Korea)

^b Dong A University   (South Korea)

^c Dong A University College of Medicine   (South Korea)

Author keywords

Cell death; Ischemia; Ischemic preconditioning; Myocytes, cardiac

Indexed keywords

PROTEIN KINASE C;

APOPTOSIS; CELL DEATH; CELL METABOLISM; CELL SURVIVAL; CYTOLOGY; HEART MUSCLE CELL; ISCHEMIA; ISCHEMIC PRECONDITIONING; MITOCHONDRION; NECROSIS; REVIEW;

EID: 33645735815     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2006.36.3.165     Document Type: Review

References (98)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world. Lancet 1997;349:1269-76.
2. Nallamothu BK, Bates ER, Herrin J, et al. Times to treatment in transfer patients undergoing primary percutaenous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 2005;111:761-7.
3. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005;115:500-8.
4. Myears DW, Sobel BE, Bergmann SR. Substrate use in ischemic and reperfused canine myocardium: quantitative considerations. Am J Physiol 1987;253:H107-14.
5. Owen P, Dennis S, Opie LH. Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. Circ Res 1990;66:344-54.
6. Bricknell OL, Opie LH. Evidence of substrate on tissue metabolic changes in the isolated rat heart during underperfusion and on release of lactate dehydrogenase and arrhythmias during reperfusion. Circ Res 1978;43:102-15.
7. Neely JR, Whitmer JT, Rovetto MJ. Effect of coronary blood flow on glycolytic flux and intracellular pH in isolated rat hearts. Circ Res 1975;37:733-41.
8. Clarke K, O'Connor AJ, Willis RJ. Temporal relation between energy metabolism and myocardial function during ischemia and reperfusion. Am J Physiol 1987;253:H412-21.
9. Kingsley-Hickman PB, Sako EY, Ugurbil K, From AH, Foker JE. 31P NMR measurement of mitochondrial uncoupling in isolated rat hearts. J Biol Chem 1990;265:1545-50.
10. Jennings RB, Reimer KA, Hill ML, Mayer SE. Total ischemia, in dog hearts, in vitro: 1. comparison of higher energy phosphate production and depletion and of adenine nucleotide catabolism in total ischemia in vitro vs. severe ischemia in vivo. Circ Res 1981;49:892-900.
11. Auffermann W, Wagner S, Wu S, Buser P, Parmley WW, Wikman-Coffelt J. Calcium inhibition of glycolysis contributes to ischemic injury. Cardiovasc Re 1990;24:510-20.
12. Butwell NB, Ramasamy R, Lazar I, Sherry AD, Malloy CR. Effect of lidocaine on contracture, intracellular sodium, and pH in ischemic rat hearts. Am J Physiol 1993;264:H1884-9.
13. 2+. Am J Phyiol 1990;259:C940-8.
14. Bersohn MM. Sodium pump inhibition in sarcolemma ischemic hearts. J Mol Cell Cardiol 1995;27:1483-9.
15. Kleber AG. Extracellular potassium accumulation in acute myocardial ischemia. J Mol Cell Cardiol 1984;16:389-94.
16. Steenbergen C, Murphy E, Levy L, London RE. Elevation of cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res 1987;60:700-7.
17. Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 2005;100:179-90.
18. Steenbergen C, Hill ML, Jennings BR. Cytoskeletal damage during myocardial ischemia: changes in vinculin immunoflourescecne staining during total in vitro ischemia in canine heart. Circ Res 1987;60:478-86.
19. Franson RC, Pang DC, Towle DW, Weglicki WB. Phospholipase A activity of highly enriched preparations of cardiac sarcolemma from hamster and dog. J Mol Cell Cardiol 1978;10: 921-30.
20. Crompton M. The mitochondrial permeabililty transition pore and its role in cell death. Biochem J 1999;341:233-49.
21. Jennings RB, Ganote CE. Structural changes in myocardium during acute ischemia. Circ Res 1974;35 (Suppl 3):156-72.
22. Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86-107.
23. Ohno M, Takemura G, Ohno A, et al. 'Apoptotic' myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with in situ nick end-labeling. Circulation 1998;98: 1422-30.
24. Majno G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 1995;146:3-15.
25. Thornberry NA, Lazebnik Y. Caspase: enemies within. Science 1998;281:1312-6.
26. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 1998;82:1111-29.
27. Elsasser A, Suzuki K, Lorenz-Meyer S, Bode C, Schaper J. The role of apoptosis in myocardial ischemia: a critical appraisal. Basic Res Cardiol 2001;96:219-26.
28. Tanaka M, Ito H, Adachi S, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messanger RNA in cultured rat cardiomyocytes. Circ Res 1994;75:426-33.
29. Freude B, Masters TN, Robicsek F, et al. Apoptosis is initiated during ischemia and completed during reperfusion. J Moll Cell Cardiol 2000;32:197-208.
30. Taimor G, Lorenz H, Hofstaetter B, Schluter KD, Piper HM. Induction of necrosis but not apoptosis after anoxia and reoxygenation in isolated adult cardiomyocytes of rat. Cardiovasc Res 1999;41:147-56.
31. Yang CH, Kim YD, Park EH, et al. Modes of cell death and surivival in cardiomyocytes under various type of ischemic injury. Korean Circ J 2003;33:949-56.
32. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997; 185:1481-6.
33. Olivetti G, Quaini F, Sala R, et al. Acute myocardial infarction in human is associated with activation of programmed cell death in the surviving portion of the heart. J Moll Cell Cardiol 1996; 28:2005-16.
34. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation 1997;95:320-3.
35. Becker LB. New concept in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004;61: 461-70.
36. Vanden Hoek TL, Qin Y, Wojcik K, et al. Reperfusion, not simulated ischemia, initiates intrinsic apoptosis injury in chick cardiomyocytes. Am J Physiol Heart Circ Physiol 2003;284: H141-50.
37. Elsasser A, Suzuki K, Schaper J. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Moll Cell Cardiol 2000;32:711-24.
38. Iordanov MS, Kirsch JD, Ryabinina OP, et al. Recruitment of TRADD, FADD, and caspase 8 to double-stranded RNA-triggered death inducing signaling complexes (dsRNA-DISCs). Apoptosis 2005;10:167-76.
39. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM. An induced proximity model for caspase-8 activation. J Biol Chem 1998;273:2926-30.
40. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-6.
41. Cheng EH, Wei MC, Weiler S, et al. Bcl-2, Bcl-XL sequester BH3 domain-only molecules preventing BAX and BAK-mediated mitochondrial apoptosis. Mol Cell 2001;8:705-11.
42. van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ, Vandenabeele P. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 2002;9:1031-42.
43. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479-89.
44. Li H, Zhu H, Zu CJ, Yuan J. Cleavage of BID by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998;94:491-501.
45. Louge SE, Gustafsson AB, Samali A, Gottleib RA. Ischemia/ reperfusion injury at the intersection with cell death. J Moll Cell Cardiol 2005;38:21-33.
46. Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res 2003;93:292-301.
47. Kim JS, He L, Lemasters JJ. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 2003;304:463-70.
48. Crow MT, Mani K, Nam YJ, Kitsis RN. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 2004; 95:957-70.
49. Borutaite V, Brown GC. Mitochondria in apoptosis of ischemic heart. FEBS letter 2003;541:1-5.
50. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
51. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993;88:1264-72.
52. Kuzuya T, Hoshida S, Yamashita N, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993;72:1293-9.
53. Hagar JM, Hale SL, Kloner RA. Effect of preconditioning ischemia on reperfusion arrhythmias after coronary occlusion and reperfusion in the rat. Circ Res 1991;68:61-8.
54. Chung NS, Na HS, Nahm SH, Oh DJ. The effect of hypoxic-preconditioning on the reperfusion-induced arrhythmia in the cat hearts. Korean Circ J 1997;27:1027-36.
55. Jennings RB, Sebbag L, Schwartz LM, Crago MS, Reiuer KA. Metabolism of preconditioning myocardium: effect of loss and reinstatement of cardioprotection. J Moll Cell Cardiol 2001;33: 1571-88.
56. Murry CE, Richard VJ, Reimer KA, Jenning RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during sustained ischemic episode. Circ Res 1990; 66:913-31.
57. Weiss RG, de Albuquerque CP, Vandegaer K, Chacko VP, Gerstenblith G. Attenuated glycolysis reduces glycolytic catabolite accumulation during ischemia in preconditioned rat hearts. Circ Res 1996;79:435-46.
58. Murphy E. Primary and secondary pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res 2004;94:7-16.
59. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-52.
60. Yoo HJ, Park JS, Kim H, et al. Ischemic preconditioning in isolated rabbit heart: effect of left ventricular function, infarct size, and protein kinase C. Korean Circ J 1996;26:541-52.
61. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contributes to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997;29:207-16.
62. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res 1994;75: 586-90.
63. Steinberg SF, Goldberg M, Rybin VO. Protein kinase C isoforms diversity in the heart. J Mol Cell Cardiol 1995;27:141-53.
64. Clark A, Bogoyevitch MA, Fuller SJ, Lazou A, Parker PJ, Sugden PH. Expression of protein kinase C isoforms during cardiac ventricular development. Am J Physiol 1995;269:H1087-97.
65. Son JW, Kim YD. PKC activation protects the cardiomyocytes from ischemic insult in adult, but not neonatal rat heart. Korean Circ J 2002;32:689-96.
66. Gray MO, Karliner JS, Mochly-Rosen D. A selective ε protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem 1997;272:30945-51.
67. Dorn GW 2nd, Souroujon MC, Liron T, et al. Sustained in vivo cardioac protection by a rationally designed peptide that causes epsiolon kinase C translocation. Proc Natl Acad Sci USA 1999; 96:12798-803.
68. Kim HC, Kim H, Chung ST, et al. Cardioprotective effect of the ischemic preconditioning: its relation to activation of protein kinase C. Korean Circ J 1999;29:602-12.
69. + production. J Moll Cell Cardiol 2002;34: 361-7.
70. + channels by protein kinase C. Circ Res 1998; 83:110-4.
71. Li RC, Ping P, Zhang Z, et al. PKC ε modulates NF- κB and AP-1 via mitogen activated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol 2000;279: H1679-89.
72. Hahn HS, Yussman MG, Toyokawa T, et al. Ischemic protection and myofibrillar cardiomyopathy: dose-dependent effect of delta PKC inhibition. Circ Res 2002;91:741-8.
73. Zaugg M, Schaub MC. Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacologic preconditioning. J Muscl Res Cell Motil 2003;24:219-49.
74. ATF channels in the isolated rabbit heart. Basic Res Cardiol 1999;94:188-98.
75. Chen Z, Chua CC, Ho YS, Hamdy RC, Chua BH. Overexpression of b cl-2 attenuates apoptosis and protects agonist myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol 2001;280:H2313-20.
76. Schwanke U, Konietzka I, Duschin A, Li X, Schulz R, Hesch G. No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol Heart Circ Physiol 2002;283: H1740-2.
77. + channel: possible mechanism of cardioprotection. Circ Res 1997;81:1072-82.
78. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels: novel effector of cardioprotection? Circulation 1998;97:2463-9.
79. + channel and their role in cardioprotection. Circ Res 2004;94:420-32.
80. ATP channels in Ischemic cardioprotection. Circulation 2000;101:2418-23.
81. 2+ overload in rat cardiac mitochondria. J Physiol 1999;519:347-60.
82. + channel protects the ischemic heart. Am J Physiol Heart Circ Physiol 2002;283:H284-95.
83. Lim KH, Javadov SA, Das M, Clarke SJ, Suleiman MS, Halestrap AP. The effect of ischemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J Physiol 2002;545:961-74.
84. Forbes RA, Steenbergen C, Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res 2001;88:802-9.
85. Cave AC, Ingwall JS, Friedrich J, et al. ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation 2000;101:2090-6.
86. Diaz R, Paolasso EA, Piegas LS, et al. Metabolic modulation of acute myocardial infarction: the ECLA (Estudios Cardiologicos Latino-america) collabrative group. Circulation 1998;98: 2227-34.
87. van der Horst IC, Zijlstra F, van't Hof AW, et al. Glucose-insulin- potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium-study: a randomized trial. J Am Coll Cardiol 2003;42:784-91.
88. + exchanger: a potential therapeutic target for the prevention of myocardial ischemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs 2001;61:375-89.
89. + exchange inhibition on infarct size in rabbits. Am J Physiol Heart Circ Physiol 2000;279:H2673-7.
90. + exchange inhibitor cariporide in infant-induced heart failure. Cardiovasc Res 2000;46:102-10.
91. + exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. Circulation 2000;101:2902-8.
92. Theroux P, Chariman BR, Danchin N, et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situation: main results of the GUARDIAN trial. Circulation 2000;102:3032-8.
93. + exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction: results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardial 2001; 38:1644-50.
94. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 1994;89:1769-75.
95. Galie N, Guarnieri C, Ussia GP, et al. Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. J Cardiovasc Pharmacol 1995;26:477-84.
96. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channel prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-33.
97. Ito H, Taniyama Y, Kwakura K, et al. Intravenous nicorandil can preserve myocardial integrity and myocardial viability in patients with reperfused anterior myocardial infarction. J Am Coll Cardiol 1999;33:654-60.
98. From Ishii H, et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 2005;112:1284-8.